Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Prenyl-IN-1

Copy Product Info
😃Good
Catalog No. T10512Cas No. 360561-53-1

Prenyl-IN-1 is a potent and selective prenylation inhibitor of geranylgeranyltransferase or farnesyltransferase.Prenyl-IN-1 shows anti-oxidative stress effects in a Parkinson's model. Prenyl-IN-1 showed anti-oxidative stress in a Parkinson's model.

Prenyl-IN-1

Prenyl-IN-1

Copy Product Info
😃Good
Catalog No. T10512Cas No. 360561-53-1
Prenyl-IN-1 is a potent and selective prenylation inhibitor of geranylgeranyltransferase or farnesyltransferase.Prenyl-IN-1 shows anti-oxidative stress effects in a Parkinson's model. Prenyl-IN-1 showed anti-oxidative stress in a Parkinson's model.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$700-In Stock
5 mg$1,800-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:>99.99%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Prenyl-IN-1 AI Summary
Prenyl-IN-1 exhibits bioactivities related to inhibiting enzymes involved in prenylation processes, specifically farnesyltransferase and geranylgeranyl transferase type I. It demonstrates varying potency in enzyme inhibition, as evidenced by its IC50 values in different assays. Additionally, the compound effectively displaces a radiolabeled farnesyltransferase inhibitor and inhibits Rap 1a processing. These activities suggest that Prenyl-IN-1 may possess potential anti-cancer properties by interfering with the post-translational modification of proteins crucial for oncogenic signaling pathways..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Prenyl-IN-1 is a potent and selective prenylation inhibitor of geranylgeranyltransferase or farnesyltransferase.Prenyl-IN-1 shows anti-oxidative stress effects in a Parkinson's model. Prenyl-IN-1 showed anti-oxidative stress in a Parkinson's model.
Chemical Properties
Molecular Weight497.98
FormulaC28H24ClN5O2
Cas No.360561-53-1
SmilesN#CC1=CC=C(C=C1OC=2C=CC=CC2)CN3C=NC=C3CN4CC(=O)N(C=5C=CC=C(Cl)C5)CC4
Relative Density.1.28 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Prenyl-IN-1 | purchase Prenyl-IN-1 | Prenyl-IN-1 cost | order Prenyl-IN-1 | Prenyl-IN-1 chemical structure | Prenyl-IN-1 formula | Prenyl-IN-1 molecular weight